| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 236,135 | 208,018 | 200,933 | 249,196 | | Cost of Revenue | 59,583 | 53,456 | 52,662 | 60,278 | | | Gross Profit | 176,552 | 154,562 | 148,271 | 188,918 | | | Operating Expenses | | Research Development | 45,340 | 44,466 | 44,724 | 45,793 | | Selling General and Administrative | 31,659 | 28,694 | 30,430 | 32,573 | | Non Recurring |
-
| 2,343 |
-
| 1,564 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 99,553 | 79,059 | 73,117 | 108,988 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,856 | 6,060 | 7,070 | 27,102 | | Earnings Before Interest And Taxes | 103,409 | 85,119 | 80,187 | 136,090 | | Interest Expense | 19,121 | 12,091 | 12,529 | 13,246 | | Income Before Tax | 84,288 | 73,028 | 67,658 | 122,844 | | Income Tax Expense | 23,601 | 16,796 | 13,193 | 27,640 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 60,687 | 56,232 | 54,465 | 95,204 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 60,687 | 56,232 | 54,465 | 95,204 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $60,687 | $56,232 | $54,465 | $95,204 |
|
0.11% Nasdaq 
0.01%
Income Statement
